Search Results - "RASMUSSEN, Søren N"

  • Showing 1 - 15 results of 15
Refine Results
  1. 1

    Development of a Long-Term Ascending Urinary Tract Infection Mouse Model for Antibiotic Treatment Studies by HVIDBERG, H, STRUVE, C, KROGFELT, K. A, CHRISTENSEN, N, RASMUSSEN, S. N, FRIMODT-MØLLER, N

    Published in Antimicrobial Agents and Chemotherapy (01-01-2000)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  2. 2

    Pharmacokinetics and pharmacodynamics of mivacurium in patients phenotypically homozygous for the atypical plasma cholinesterase variant : Effect of injection of human cholinesterase by ØSTERGAARD, Doris, VIBY-MOGENSEN, Jørgen, RASMUSSEN, Søren N, GÄTKE, Mona R, VARIN, France

    Published in Anesthesiology (Philadelphia) (01-06-2005)
    “…In patients homozygous for atypical plasma cholinesterase, mivacurium causes a long-lasting neuromuscular block, but injection of human cholinesterase has been…”
    Get full text
    Journal Article
  3. 3

    Absorption and Retention of Nickel from Drinking Water in Relation to Food Intake and Nickel Sensitivity by Nielsen, Gitte Dalsgaard, Søderberg, Ulla, Jørgensen, Poul J., Templeton, Douglas M., Rasmussen, Søren N., Andersen, Klaus E., Grandjean, Philippe

    Published in Toxicology and applied pharmacology (01-01-1999)
    “…Two studies were performed to examine the influence of fasting and food intake on the absorption and retention of nickel added to drinking water and to…”
    Get full text
    Journal Article
  4. 4

    The influence of drug-induced low plasma cholinesterase activity on the pharmacokinetics and pharmacodynamics of mivacurium by ØSTERGAARD, D, RASMUSSEN, S. N, VIBY-MOGENSEN, J, PEDERSEN, N. A, BOYSEN, R

    Published in Anesthesiology (Philadelphia) (01-06-2000)
    “…The short duration of action of mivacurium results from its rapid hydrolysis by plasma cholinesterase. Bambuterol, an oral bronchodilator, has an inhibiting…”
    Get full text
    Journal Article
  5. 5

    Stereoselective pharmacokinetics of methadone in chronic pain patients by KRISTENSEN, K, BLEMMER, T, ANGELO, H. R, CHRISTRUP, L. L, DRENCK, N. E, RASMUSSEN, S. N, SJØGREN, P

    Published in Therapeutic drug monitoring (01-06-1996)
    “…Ten patients with chronic pain were randomized to an open, balanced, crossover study. Each patients received two different preparations of racemic methadone,…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Pharmacokinetics and Pharmacodynamics of Mivacurium in Patients Phenotypically Homozygous for the Atypical Plasma Cholinesterase Variant by Østergaard, Doris, Viby-Mogensen, Jørgen, Rasmussen, Søren N., Gätke, Mona R., Varin, France

    Published in Anesthesiology (Philadelphia) (01-06-2005)
    “…Background In patients homozygous for atypical plasma cholinesterase, mivacurium causes a long-lasting neuromuscular block, but injection of human…”
    Get full text
    Journal Article
  8. 8

    Phenytoin pharmacokinetics in critically ill trauma patients by Boucher, B A, Rodman, J H, Jaresko, G S, Rasmussen, S N, Watridge, C B, Fabian, T C

    Published in Clinical pharmacology and therapeutics (01-12-1988)
    “…Preliminary data have suggested that phenytoin systemic clearance may increase during initial therapy in critically ill patients. The objectives for this study…”
    Get more information
    Journal Article
  9. 9

    Pharmacokinetics of oral idarubicin in breast cancer patients with reference to antitumor activity and side effects by Elbaek, K, Ebbehøj, E, Jakobsen, A, Juul, P, Rasmussen, S N, Bastholt, L, Dalmark, M, Steiness, E

    Published in Clinical pharmacology and therapeutics (01-06-1989)
    “…The pharmacokinetics of orally administered idarubicin (22.5 mg/m2/week) and idarubicinol were studied for 12 weeks in 14 patients with breast cancer. Plasma…”
    Get more information
    Journal Article
  10. 10

    Pharmacokinetics of tinzaparin (Logiparin)--a low molecular weight heparin--after single and repeated intravenous administration in rats by Johansen, P B, Rasmussen, S N, Ostergaard, P B

    Published in Thrombosis research (15-08-1994)
    “…After a single and repeated i.v. injections of 1 mg/kg 3H-radiolabelled tinzaparin once daily to rats for 7, 14, and 21 days, drug-related radioactivity in…”
    Get more information
    Journal Article
  11. 11

    Pharmacokinetics of doxorubicin and its metabolite doxorubicinol in rabbits with induced acid and alkaline urine by JOHANSEN, P. B, JENSEN, S. E, RASMUSSEN, S. N, DALMARK, M

    Published in Cancer chemotherapy and pharmacology (01-01-1984)
    “…The pharmacokinetics of doxorubicin in rabbits preloaded either with ammonium chloride or sodium hydrogencarbonate have been investigated following single IV…”
    Get full text
    Journal Article
  12. 12

    Comparative responsiveness and pharmacokinetics of doxorubicin in human tumor xenografts by Wassermann, K, Rasmussen, S N

    “…The antineoplastic activity of the anthracycline antibiotic doxorubicin (Adriamycin) differs in its cytotoxic effectiveness against different types of human…”
    Get more information
    Journal Article
  13. 13

    Single-dose and steady-state pharmacokinetics of diltiazem administered in two different tablet formulations by Christrup, L L, Bonde, J, Rasmussen, S N, Sonnergaard, J M, Jensen, B H

    Published in Pharmacology & toxicology (01-10-1992)
    “…Single-dose and steady state pharmacokinetics of diltiazem administered in two different oral formulations were assessed with particular reference to rate and…”
    Get more information
    Journal Article
  14. 14

    Single intravenous and oral doses of fenflumizole: pharmacokinetics and effects on prostanoid formation by Vinge, E, Arnold, E, Rasmussen, S N, Midskov, C

    Published in Acta pharmacologica et toxicologica (01-08-1985)
    “…Fenflumizole is a substituted triaryl-imidazole with anti-inflammatory activity. Its disposition in man was studied after single intravenous and oral doses to…”
    Get more information
    Journal Article
  15. 15

    Phenytoin prodrug 3-phosphoryloxymethyl phenytoin (ACC-9653): pharmacokinetics in patients following intravenous and intramuscular administration by Boucher, B A, Bombassaro, A M, Rasmussen, S N, Watridge, C B, Achari, R, Turlapaty, P

    Published in Journal of pharmaceutical sciences (01-11-1989)
    “…A phenytoin prodrug, 3-phosphoryloxymethyl phenytoin (ACC-9653; 1), has been developed with more favorable physicochemical properties than phenytoin for…”
    Get more information
    Journal Article